TW202342072A - 以環糊精治療高三酸甘油脂血症之方法 - Google Patents

以環糊精治療高三酸甘油脂血症之方法 Download PDF

Info

Publication number
TW202342072A
TW202342072A TW112105977A TW112105977A TW202342072A TW 202342072 A TW202342072 A TW 202342072A TW 112105977 A TW112105977 A TW 112105977A TW 112105977 A TW112105977 A TW 112105977A TW 202342072 A TW202342072 A TW 202342072A
Authority
TW
Taiwan
Prior art keywords
amount
subject
administration
therapeutically effective
cyclodextrin
Prior art date
Application number
TW112105977A
Other languages
English (en)
Chinese (zh)
Inventor
傑森 卡姆
Original Assignee
美商貝倫治療公益公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商貝倫治療公益公司 filed Critical 美商貝倫治療公益公司
Publication of TW202342072A publication Critical patent/TW202342072A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
TW112105977A 2022-02-18 2023-02-18 以環糊精治療高三酸甘油脂血症之方法 TW202342072A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263311536P 2022-02-18 2022-02-18
US63/311,536 2022-02-18

Publications (1)

Publication Number Publication Date
TW202342072A true TW202342072A (zh) 2023-11-01

Family

ID=85476260

Family Applications (1)

Application Number Title Priority Date Filing Date
TW112105977A TW202342072A (zh) 2022-02-18 2023-02-18 以環糊精治療高三酸甘油脂血症之方法

Country Status (11)

Country Link
US (1) US20240398849A1 (cg-RX-API-DMAC7.html)
EP (1) EP4479064A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025508660A (cg-RX-API-DMAC7.html)
KR (1) KR20240148426A (cg-RX-API-DMAC7.html)
CN (1) CN118715017A (cg-RX-API-DMAC7.html)
AU (1) AU2023222567A1 (cg-RX-API-DMAC7.html)
CA (1) CA3244447A1 (cg-RX-API-DMAC7.html)
IL (1) IL315046A (cg-RX-API-DMAC7.html)
MX (1) MX2024010110A (cg-RX-API-DMAC7.html)
TW (1) TW202342072A (cg-RX-API-DMAC7.html)
WO (1) WO2023156970A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003063824A2 (en) * 2002-02-01 2003-08-07 Shimoda Biotech (Pty) Ltd Pharmaceutical composition
CN1745746A (zh) * 2004-09-09 2006-03-15 天津药物研究院 冰片的羟丙基-β-环糊精包合物及其制剂和制备方法
CN1961892A (zh) * 2005-11-08 2007-05-16 天津药物研究院 降香羟丙基-β-环糊精包合物及其制剂和制备方法
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
JP5847721B2 (ja) * 2009-10-08 2016-01-27 ソン、ホ、バイオメッド、カンパニー、リミテッドSong Ho Biomed Co., Ltd 高水溶性2−ヒドロキシプロピル−ベータシクロデキストリンを有効成分として含有する、肥満疾患の予防および治療用組成物
FR3014694B1 (fr) * 2013-12-13 2016-11-11 Roquette Freres Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl

Also Published As

Publication number Publication date
CA3244447A1 (en) 2023-08-24
AU2023222567A1 (en) 2024-09-19
EP4479064A1 (en) 2024-12-25
US20240398849A1 (en) 2024-12-05
KR20240148426A (ko) 2024-10-11
IL315046A (en) 2024-10-01
MX2024010110A (es) 2024-08-30
CN118715017A (zh) 2024-09-27
JP2025508660A (ja) 2025-04-10
WO2023156970A1 (en) 2023-08-24

Similar Documents

Publication Publication Date Title
JP7446322B2 (ja) アルツハイマー病を治療する方法
JP7835735B2 (ja) シクロデキストリンによるコレステロール結晶塞栓症の治療方法
US20240082242A1 (en) Combination therapies
US20240398849A1 (en) Methods for the treatment of hypertriglyceridemia with cyclodextrins
US20230091966A1 (en) Methods for the treatment of cardiovascular disease with cyclodextrins
US20260124236A1 (en) Methods for treating early alzheimer’s disease
JP2024509376A (ja) 家族性ヘテロ接合型及びホモ接合型高コレステロール血症のシクロデキストリンによる治療方法
US20230302042A1 (en) Methods for the prevention of cholesterol crystal embolization with cyclodextrins
US20210369657A1 (en) Reducing triglyceride levels and cortisol levels with pharmaceutical preparations
JP2014208713A (ja) 冠動脈の描出能改善剤